Tuesday, October 21 Janssen Pharmaceuticals has initiated a voluntary recall of 13,500 bottles of its anticoagulant drug Xarelto citing microbial contamination. In its most recent Enforcement Report, issued for the week of October 15, the U.S. Food and Drug Administration indicated that Janssen notified the agency of the problem by letter dated September 17. The company...Read more
Janssen is a subsidiary company of Johnson & Johnson, a major pharmaceutical company. Learn more about litigation against the companies by exploring our site.